Rini B - Search Results

1

Differential expression of caveolin-1 in renal neoplasms.

Tamaskar I, Choueiri TK, Sercia L, Rini B, Bukowski R, Zhou M. Tamaskar I, et al. Among authors: rini b. Cancer. 2007 Aug 15;110(4):776-82. doi: 10.1002/cncr.22838. Cancer. 2007. PMID: 17594718 Free article.

2

Time to disease progression to evaluate a novel protein kinase C inhibitor, UCN-01, in renal cell carcinoma.

Rini BI, Weinberg V, Shaw V, Scott J, Bok R, Park JW, Small EJ. Rini BI, et al. Cancer. 2004 Jul 1;101(1):90-5. doi: 10.1002/cncr.20313. Cancer. 2004. PMID: 15221993 Free article. Clinical Trial.

3

A phase I trial of fixed dose rate gemcitabine and capecitabine in metastatic renal cell carcinoma.

Rini BI, Weinberg V, Small EJ. Rini BI, et al. Cancer. 2005 Feb 1;103(3):553-8. doi: 10.1002/cncr.20795. Cancer. 2005. PMID: 15612026 Free article. Clinical Trial.

4

Maximal COX-2 immunostaining and clinical response to celecoxib and interferon alpha therapy in metastatic renal cell carcinoma.

Rini BI, Weinberg V, Dunlap S, Elchinoff A, Yu N, Bok R, Simko J, Small EJ. Rini BI, et al. Cancer. 2006 Feb 1;106(3):566-75. doi: 10.1002/cncr.21661. Cancer. 2006. PMID: 16369983 Free article. Clinical Trial.

5

SU11248 and AG013736: current data and future trials in renal cell carcinoma.

Rini BI. Rini BI. Clin Genitourin Cancer. 2005 Dec;4(3):175-80. doi: 10.3816/CGC.2005.n.029. Clin Genitourin Cancer. 2005. PMID: 16425985 Review.

6

Combination immunotherapy with prostatic acid phosphatase pulsed antigen-presenting cells (provenge) plus bevacizumab in patients with serologic progression of prostate cancer after definitive local therapy.

Rini BI, Weinberg V, Fong L, Conry S, Hershberg RM, Small EJ. Rini BI, et al. Cancer. 2006 Jul 1;107(1):67-74. doi: 10.1002/cncr.21956. Cancer. 2006. PMID: 16736512 Free article. Clinical Trial.

7

Sunitinib in patients with metastatic renal cell carcinoma.

Motzer RJ, Rini BI, Bukowski RM, Curti BD, George DJ, Hudes GR, Redman BG, Margolin KA, Merchan JR, Wilding G, Ginsberg MS, Bacik J, Kim ST, Baum CM, Michaelson MD. Motzer RJ, et al. JAMA. 2006 Jun 7;295(21):2516-24. doi: 10.1001/jama.295.21.2516. JAMA. 2006. PMID: 16757724 Clinical Trial.

8

Clinical activity of sorafenib and sunitinib in renal cell carcinoma refractory to previous vascular endothelial growth factor-targeted therapy: two case reports.

Shaheen PE, Rini BI, Bukowski RM. Shaheen PE, et al. Clin Genitourin Cancer. 2006 Jun;5(1):78-81. doi: 10.3816/CGC.2006.n.021. Clin Genitourin Cancer. 2006. PMID: 16859583

9

Current status and future directions of molecular markers in renal cell carcinoma.

Rini BI. Rini BI. Curr Opin Urol. 2006 Sep;16(5):332-6. doi: 10.1097/01.mou.0000240304.96131.44. Curr Opin Urol. 2006. PMID: 16905977 Review.

10

The current role of angiogenesis inhibitors in the treatment of renal cell carcinoma.

Choueiri TK, Bukowski RM, Rini BI. Choueiri TK, et al. Semin Oncol. 2006 Oct;33(5):596-606. doi: 10.1053/j.seminoncol.2006.06.003. Semin Oncol. 2006. PMID: 17045089 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

530 results

Search Page

Filters